Corrigendum to “SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function” [Biomed. Pharmacother. 151 (2022) 113080] - 23/04/26

Fei Yang ^{a, b,} 1

  Co-first author.

, Xiaoqiang Zhu ^b, 1

  Co-first author.

, Liu Li ^a, Yanping Wang ^a, Qing Xie ^a, Yu Cao ^b, Yunhui Yu ^b, Minjie Zhang ^b, Dong Li ^b, Ling Li ^b, Zhongtian Liu ^b, Biyan Zhang ^b, Zijun Chen ^{c, ⁎} , Shiping Deng ^{b, ⁎} , Yunsen Li ^{a, ⁎}

^a Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China 

^b Suzhou Pharmavan Co.,Ltd, Suzhou, Jiangsu 215127, China 

^c School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China 

^⁎ Corresponding authors.

Le texte complet de cet article est disponible en PDF.